-38% Off

Zidolam-N

840

Generic Name: Zidovudine, Lamivudine & Nevirapine Tablets

Zidolam-N is a medication used in the treatment of HIV (human immunodeficiency virus) infection. It is a combination of three active ingredients: zidovudine, lamivudine and Nevirapine.

Category:

Description

Description

Generic Name: Zidovudine, Lamivudine & Nevirapine Tablets

Composition:
ZIDOLAM-N
Each film coated tablet contains:
Zidovudine 300mg, Lamivudine 150mg & Nevirapine 200mg Tablets
Zidovudine IP – 300 mg
Lamivudine IP – 150 mg
Nevirapine IP – 200mg

Indication:
ZIDOLAM-N: A three-drug combination of Zidovudine (AZT), Lamivudine (3TC) and Nevirapine
(NPV) is indicated as a complete regimen or in combination with other antiretroviral agents for
the treatment of HIV-1 infection.

Additional information

Additional information

Pack

60 Tab

Composition

Each film coated tablet contains:
Zidovudine 300mg, Lamivudine 150mg & Nevirapine 200mg Tablets
Zidovudine IP – 300 mg
Lamivudine IP – 150 mg
Nevirapine IP – 200mg

Manufacturer

HETERO

Reviews (0)

Reviews

There are no reviews yet.

Share Your Feedback

Be the first to review “Zidolam-N”

Your email address will not be published. Required fields are marked *

FAQ

Description

Generic Name: Zidovudine, Lamivudine & Nevirapine Tablets

Composition:
ZIDOLAM-N
Each film coated tablet contains:
Zidovudine 300mg, Lamivudine 150mg & Nevirapine 200mg Tablets
Zidovudine IP – 300 mg
Lamivudine IP – 150 mg
Nevirapine IP – 200mg

Indication:
ZIDOLAM-N: A three-drug combination of Zidovudine (AZT), Lamivudine (3TC) and Nevirapine
(NPV) is indicated as a complete regimen or in combination with other antiretroviral agents for
the treatment of HIV-1 infection.

Additional information

Pack

60 Tab

Composition

Each film coated tablet contains:
Zidovudine 300mg, Lamivudine 150mg & Nevirapine 200mg Tablets
Zidovudine IP – 300 mg
Lamivudine IP – 150 mg
Nevirapine IP – 200mg

Manufacturer

HETERO

Reviews

There are no reviews yet.

Share Your Feedback

Be the first to review “Zidolam-N”

Your email address will not be published. Required fields are marked *